Skip to content

The Effect of Peer Comparison Emails on Oncologists' Documentation of Cancer Stage

The Effect of Peer Comparison Emails on Oncologists' Documentation of Cancer Stage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04298762
Enrollment
56
Registered
2020-03-06
Start date
2018-07-01
Completion date
2019-09-30
Last updated
2020-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oncology

Brief summary

Documenting cancer stage is the most important determinant of treatment approach and survival for cancer patients. However, oncologists do not routinely document a patient's cancer stage in the structured field in electronic health records. This quality improvement pilot study evaluated the impact of sending an email to physicians at a cancer center of a large academic hospital with individualized data on their rates of cancer stage documentation using a structured field. The investigators assessed patient-level documentation and physician-level rates of staging documentation over 15 months including a three-month pre-period, a six-month pilot phase and a six-month follow-up period. The investigators also estimated staging documentation rates separately for each physician's new versus established patients.

Interventions

OTHERNo peer comparison email

The comparison group received no email communication on their cancer stage documentation activity.

OTHERPeer comparison email

The intervention group received three separate emails with individualized data on their cancer stage documentation activity in the previous 1-3 months. The email described the number and percent of attributed patients for whom cancer stage was documented, and included a figure showing their staging documentation rate compared to their peers.

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Harvard School of Public Health (HSPH)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Attending physicians who had been at one of three sites of hospital between January - August 2018

Exclusion criteria

* Physicians treating cancer patients where American Joint Committee on Cancer (AJCC) staging modules were less clinically relevant * Physicians with low clinical volume (\<5 patients over 3 months) * Physicians without any outpatient visits

Design outcomes

Primary

MeasureTime frameDescription
Measuring if a patient's cancer stage was documented in a structured field in the Electronic Health Record on the date of the patient's first ambulatory care visit15 monthsIndicator of whether the structured field for cancer stage in the patient's electronic health record (EHR) was populated on the date of the first outpatient encounter that a patient had during the study period (1=yes, 0=no)

Secondary

MeasureTime frameDescription
Staging documentation rate (monthly)15 monthsPercentage of patients whose first outpatient encounter occurred in a given month for whom cancer stage was documented

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026